PhaseRx, Inc.
PZRXQ
$0.00
$0.000.00%
OTC PK
| 09/30/2017 | 06/30/2017 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -24.32% | -32.98% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -23.64% | -15.20% | |||
| Operating Income | 23.64% | 15.20% | |||
| Income Before Tax | 22.29% | 14.21% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 22.29% | 14.21% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 22.29% | 14.21% | |||
| EBIT | 23.64% | 15.20% | |||
| EBITDA | 23.76% | 15.28% | |||
| EPS Basic | 22.30% | 14.22% | |||
| Normalized Basic EPS | 22.30% | 14.20% | |||
| EPS Diluted | 22.30% | 14.22% | |||
| Normalized Diluted EPS | 22.30% | 14.20% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||